Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fluor
FLR
$7.2B
| $307M | 0.03% |
5,287,935
-443,142
| -8% | -$24.1M |
|
502
Sally Beauty Holdings
SBH
$1.48B
| $304M | 0.03% |
16,553,796
+1,478,733
| +10% | +$23.6M |
|
503
Reinsurance Group of America
RGA
$15.5B
| $304M | 0.03% |
2,103,056
-258,126
| -11% | -$36.5M |
|
504
Halliburton
HAL
$26.5B
| $304M | 0.03% |
7,498,687
-1,711,695
| -19% | -$70.8M |
|
505
Heron Therapeutics
HRTX
$95.5M
| $304M | 0.03% |
9,589,513
-1,701,443
| -15% | -$63.4M |
|
506
Ameriprise Financial
AMP
$49.6B
| $303M | 0.03% |
2,052,632
-26,723
| -1% | -$3.82M |
|
|
EBIX
507
DELISTED
Ebix Inc
EBIX
| $303M | 0.03% |
3,827,062
+83,421
| +2% | +$6.64M |
|
508
eBay
EBAY
$49.4B
| $303M | 0.03% |
9,173,388
-7,838,061
| -46% | -$272M |
|
509
Magnolia Oil & Gas
MGY
$5.62B
| $302M | 0.03% |
20,119,900
+17,784,800
| +762% | +$232M |
|
510
Travel + Leisure Co
TNL
$4.77B
| $302M | 0.03% |
6,963,896
-466,325
| -6% | -$20.7M |
|
511
Steris
STE
$22.7B
| $301M | 0.03% |
2,630,670
+29,062
| +1% | +$3.29M |
|
512
HEICO Corp Class A
HEI.A
$37.2B
| $301M | 0.03% |
3,984,062
-477,085
| -11% | -$32.8M |
|
513
NETGEAR
NTGR
$659M
| $300M | 0.03% |
4,771,168
+41,604
| +0.9% | +$2.84M |
|
514
Ziff Davis
ZD
$2.04B
| $298M | 0.03% |
4,139,808
-1,375,719
| -25% | -$101M |
|
515
Genpact
G
$6.07B
| $298M | 0.03% |
9,728,731
-84,856
| -0.9% | -$2.58M |
|
|
GBT
516
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $297M | 0.03% |
7,807,836
+1,357,642
| +21% | +$60.1M |
|
517
New Oriental
EDU
$9.06B
| $297M | 0.03% |
4,007,179
-6,967
| -0.2% | -$578K |
|
518
Enterprise Products Partners
EPD
$81.6B
| $295M | 0.03% |
10,273,589
-1,249,471
| -11% | -$36.1M |
|
519
Newmont
NEM
$110B
| $295M | 0.03% |
9,763,576
+2,359,109
| +32% | +$79.8M |
|
|
TIF
520
DELISTED
Tiffany & Co.
TIF
| $295M | 0.03% |
2,284,486
-141,523
| -6% | -$18.5M |
|
521
Dominion Energy
D
$60B
| $294M | 0.03% |
4,189,492
+319,075
| +8% | +$22.6M |
|
522
Ascendis Pharma A/S
ASND
$16B
| $294M | 0.03% |
4,152,262
+812,468
| +24% | +$55.9M |
|
|
GRFS
523
Grifois
GRFS
$5.4B
| $294M | 0.03% |
13,763,759
+6,600,205
| +92% | +$139M |
|
524
iShares S&P Small-Cap 600 Value ETF
IJS
$8.32B
| $294M | 0.03% |
3,518,914
+177,720
| +5% | +$15M |
|
525
Emerson Electric
EMR
$90.6B
| $293M | 0.03% |
3,822,068
+391,320
| +11% | +$28.9M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.